XRTX: XORTX Therapeutics Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
XORTX Therapeutics Inc. (XRTX) uchun o'sish aksiyalarining qadrsizlanganlik koeffitsiyenti joriy bozor qiymatini aks ettiradi, bunda 0.00 ko'rsatkichi joriy metrikaga mos keladi. Ushbu tendentsiya klinikalarga nefrologik agentlarni yetkazib berish ustidan qat'iy nazorat va polikistoz buyrak kasalligiga qarshi kurashish uchun modifikatsiyalangan oksipurinol sinovlarining kengaytirilishi bilan bog'liq. Istiqbollar buyrak yetishmovchiligini sekinlashtiruvchi dori vositalarining ishlab chiqilishiga tayanadi, bu esa barqaror talab va yuqori patent marjalarini ta'minlaydi.
XORTX (XRTX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati XORTX Therapeutics Inc.|XRTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi XORTX Therapeutics|XRTX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar XORTX Therapeutics Inc.|XRTX - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzdorligi XORTX Therapeutics|Shoshilinch likvidlik xortx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
XRTX - Kompaniyaning sof foydasi|Kutilayotgan sof daromad XORTX Therapeutics Inc.|XRTX - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati XORTX Therapeutics|XRTX - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati XORTX Therapeutics Inc.|XRTX - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda XORTX Therapeutics|XRTX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati xortx.com|XRTX - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi XORTX Therapeutics Inc.
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:XRTX - XORTX Therapeutics Inc.
XORTX Therapeutics Inc. (XRTX) aniq buyrak terapiyasi uchun yopiq ilmiy ekotizimni ishlab chiqmoqda, bunda xususiy ishlanmalar foydani kengaytirish uchun yuqori salohiyat yaratadi. PEG koeffitsiyentini tahlil qilish orqali investor aksiyaning bozor qiymatini sof daromadning o'sish sur'atiga nisbatan baholaydi; birdan past qiymat aktivning fundamental jihatdan past baholanganligini tasdiqlaydi va biznes kapitalizatsiyasi o'sishi uchun yashirin salohiyat mavjudligidan dalolat beradi.
XORTX Therapeutics Inc. kimlar bilan raqobatlashadi
ARGX (Argenx) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (biontech.de)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax S.A. (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|Protagonist Therapeutics, Inc. (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant Therapeutics (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori adaptivebiotech.com|Narxning foydaga va o‘sish sur’atiga nisbati Celldex (CLDX)|Aurinia Pharmaceuticals Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (biocryst.com)|Vera Therapeutics, Inc. (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Therapeutics, Inc. - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PHVS|ABCL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tourmaline Corp (TRML)|PGEN (precigen.com) - PEG multiplikatori|PEG multiplikatori Pharming Corp|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|UPB (Upstream Bio Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Bio ZBIO|IMNM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharmaceuticals KALV|Septerna (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|pieris.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc) - PEG multiplikatori|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|ATXS (Astria Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Holdings Inc. ENGN|PEG multiplikatori RAPT Therapeutics Inc. RAPT|Aerovate Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Aclaris Therapeutics Inc.|Kyverna (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Tiziana Life Sciences (TLSA)|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio Inc.|Ventyx Biosciences (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori THTX|PEG multiplikatori Avalo Therapeutics Inc. (AVTX)|PEG multiplikatori ELDN (eledon.com)|AGEN - Narx-foyda va o‘sish multiplikatori|CLYM: Narx-foyda va o‘sish multiplikatori|ZURA (Zura Bio Limited) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ATYR: PEG multiplikatori|Adagene (ADAG) - PEG multiplikatori|IMA (ikenaoncology.com) - PEG multiplikatori|shattucklabs.com (STTK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Equillium Inc (EQ)|Connect Pharma - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Immunic, Inc. IMUX|ATRA - Narx-foyda va o‘sish multiplikatori|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|XFOR: Narxning foydaga va o‘sish sur’atiga nisbati|ACET: PEG multiplikatori|Celularity Corp (CELU) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio|Barinthus Biotherapeutics plc (BRNS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori KZR|SABS: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AKTX (Akari Therapeutics, Plc)|ENLV (Enlivex Therapeutics, Ltd.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|QTTB: Narx-foyda va o‘sish multiplikatori|GOVX - PEG multiplikatori|Edesa Biotech Corp (EDSA) - Narxning foydaga va o‘sish sur’atiga nisbati|IBIO - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati carismatx.com|XTLB: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Bolt Biotherapeutics Inc. (BOLT)|HCWB (HCW Biologics) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Aptevo Therapeutics - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori AIM ImmunoTech Inc. AIM|Aditxt Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti GRI (GRI Bio, Inc.)|Vyome Holdings Inc. (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Revelation Bio (REVB) - PEG multiplikatori|INDP (Indaptus Corp) - PEG multiplikatori|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|Narx-foyda va o‘sish multiplikatori Affimed N.V. AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics ITOS|Ocean Biomedical (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|tcbiopharm.com (TCBP) - PEG multiplikatori|THRD (Third Harmonic Bio Inc.) - PEG multiplikatori
